KILITCH logo

Kilitch Drugs India LTD

KILITCH·NSE·
170.55 -4.09 (-2.34%)
Market Cap590.85 Cr
PE Ratio19.76
Volume17,524
Day High - Low175.99 - 170.00
52W High-Low439.00 - 117.25
DocStoX Score
5.3/10
Weak
Fair Value
Sign in to see
ROE
12.50%
Average
P/E
19.76x
Fair
Debt / Equity
0.26
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day170.00
175.99
52W117.25
439.00
DocStoX take

Supported by growth (10.0) and risk (6.9), but held back by momentum (0.2). Growth looks strong at 10.0, but that is offset by momentum at 0.2. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.3
/10
Weak
Quality
Modest
ROE 12.5%
Valuation
Rich
P/E 19.8×
Growth
Strong
Revenue +28.1% 5Y CAGR
Risk
Moderate
D/E 0.26
Momentum
Weak
17% of 52-week range

At a glance

Market Cap
₹591 Cr
52W High / Low
₹439 / ₹117
Dividend Yield
0.00%
Promoter Holding
63.77%
EPS (TTM)
₹8.63
Book Value
₹80.00

Key highlights

  • Profit compounding 50% a year
  • Revenue compounding 28% a year
  • Profitable in all of the last 5 years
  • Momentum is weak (0.2/10)
  • Near the bottom of its 52-week range (17%)
3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

KILITCH DRUGS INDIA LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.